TKG Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,612
Closed -$827K 96
2022
Q4
$827K Buy
1,612
+805
+100% +$409K 0.54% 44
2022
Q3
$367K Sell
807
-6,020
-88% -$2.88M 0.29% 56
2022
Q2
$3.29M Buy
+6,827
New +$3.38M 2.83% 8

Other funds holding ELV

TKG Advisors's ELV Position: Q1 2023 in Review

TKG Advisors sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 1,612 shares — an estimated $827K sold.

TKG Advisors first reported a position in ELV in Q2 2022 and held it in 3 quarters. The position peaked at $3.29M in Q2 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • TKG Advisors reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • TKG Advisors sold 1,612 Elevance Health shares in Q1 2023, an estimated $827K.
  • TKG Advisors first reported a position in Elevance Health in Q2 2022 and held it in 3 quarters.
  • TKG Advisors's Elevance Health position peaked at $3.29M in Q2 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on TKG Advisors's 13F filing for Q1 2023, filed 19 Apr 2023.